Opportunity

Simpler Grants.gov #RFA-OH-26-024

Expansion and Management of the National Mesothelioma Virtual Bank for Research

Buyer

Centers for Disease Control and Prevention - ERA

Posted

October 04, 2023

Respond By

March 23, 2026

Identifier

RFA-OH-26-024

NAICS

541715

This opportunity from the Centers for Disease Control and Prevention - ERA seeks to support the continuation and expansion of the National Mesothelioma Virtual Bank (NMVB) for translational research. - Government Buyer: - Centers for Disease Control and Prevention (CDC) - Office: ERA (Extramural Research Administration) - Scope of Work: - Manage and enhance the NMVB, a national resource for malignant mesothelioma research - Maintain and expand a virtual registry and tissue bank - Provide biospecimens (fresh frozen tumor and control tissues, paraffin embedded tissues, blood, DNA samples) and associated demographic and clinical data to biomedical researchers - Facilitate a network of participating institutions sharing tissue samples and data via a centralized, Internet-based database - Requirements: - Applicants must have an established registry and tissue bank capable of serving as a national virtual resource - Must ensure public access to biospecimens and data for research purposes - No specific OEMs or commercial vendors are mentioned, as this is a grant for research infrastructure and management, not for procurement of commercial products or equipment.

Description

This funding opportunity aims to continue and expand the National Mesothelioma Virtual Bank (NMVB) to support biomedical research on malignant mesothelioma. The NMVB provides biospecimens, demographic, clinical, and molecular data to researchers to aid in the identification of disease markers and treatment improvements. The awardee will manage and enhance the virtual registry and tissue bank, which includes multiple participating institutions sharing mesothelioma tissue samples and related data through a centralized network. The goal is to improve resources available to the biomedical research community and ultimately improve health outcomes for mesothelioma patients.

View original listing